Perrigo Company v. United States of America

  1. July 05, 2024

    Top Federal Tax Cases To Watch In The 2nd Half Of 2024

    In the coming months, the U.S. Treasury and the IRS will defend rules designed to go after what they consider as abusive tax practices, including the economic substance doctrine, the Corporate Transparency Act and the moratorium on employee retention tax credits. Here, Law360 looks at key federal tax cases to watch in the rest of 2024.

  2. July 15, 2022

    International Tax Cases To Watch In The Second Half Of 2022

    Tax practitioners will have several high-stakes cases to track during the second half of 2022, including disputes brought by major U.S. multinational corporations that have accused the federal government of overstepping when writing regulations and reallocating foreign profits. Here, Law360 looks at eight key international tax cases to follow during the second half of 2022.

  3. January 03, 2022

    International Tax Cases To Watch In 2022

    Courts will continue grappling this year with high-stakes cases brought by major U.S. multinationals that have accused federal tax authorities of overstepping, with disputes including FedEx's challenge to repatriation regulations and Facebook's fight against multibillion-dollar adjustments to its tax bill. Here, Law360 looks at eight key international tax cases to follow in 2022.

  4. August 26, 2021

    Heartburn Drug's Success Unforeseeable, Perrigo Tells Court

    Perrigo told a Michigan federal court that a trial showed the drugmaker couldn't have foreseen the success of its heartburn medication — and an Israeli affiliate's related profits — while the U.S. government maintained the subsidiary was created for tax avoidance.

  5. June 07, 2021

    Perrigo Drug's Pricing Way Off, Expert Says In $163M Tax Trial

    The $466 million an Israeli subsidiary of Irish drugmaker Perrigo Co. earned from sales of a heartburn medication "in no way can possibly comply" with transfer pricing law, an economist said Monday during the company's $163 million tax trial.

  6. May 18, 2021

    Perrigo, Gov't Square Off Ahead of $163M Tax Refund Trial

    Irish drugmaker Perrigo Co. told a Michigan federal court that the Internal Revenue Service misattributed earnings that belong to the company's Israeli affiliate, while the U.S. government contended that the entity was an "overseas shoebox" that lacked economic substance.    

  7. January 12, 2021

    Perrigo Urges US Judge Not To Delay $163.5M Tax Trial

    Irish drugmaker Perrigo Co. urged a Michigan federal judge Tuesday not to further delay the trial of its $163.5 million tax refund case, countering government concerns over the court's ability to conduct a safe in-person proceeding.

  8. May 01, 2020

    COVID-19 IP Catch-Up: Looming Trials, Jeff Dunham's Dummy

    The copyright and patent offices have pushed back certain deadlines as the COVID-19 pandemic continues, while at least one intellectual property bench trial is about to proceed over video. Here, Law360 pulls together all the updates you might have missed, including victories for 3M in its trademark campaign and a new suit by comedian Jeff Dunham seeking to protect his image.

  9. April 28, 2020

    Perrigo's $163.5M Tax Trial Dates Canceled Amid Virus

    A Michigan federal judge Tuesday canceled trial dates scheduled in Perrigo's $163.5 million tax refund suit because of health concerns surrounding the coronavirus and said the trial could not proceed by video because of the complexities posed by the case.

  10. February 14, 2020

    Israeli Drugmaker Can Intervene In $163M Perrigo-US Row

    A Michigan federal judge on Friday partially granted an Israeli drugmaker permission to intervene in Perrigo's suit to recoup a $163.5 million tax refund, but only to the extent necessary to safeguard its trade secrets.